Boots Healthcare International has picked St Luke’s to help with
the UK launch of a new range of skincare products, Lutsia Laboratoires’
so-called dermacostics.
Dermacostics are positioned mid-way between the glamour of expensive
skincare brands and the clinical rigour of dermatological lines such as
Boots E45.
Boots is attempting to move beyond straightforward retail by developing
a sizeable international brand portfolio.
Boots acquired the French company, Lutsia, from Roussel Uclaf for pounds
115 million last year. In France, it markets Lutsine, an anti-acne
product and Onagrine, an anti-ageing cream, with combined sales worth
around pounds 40 million.
The Lutsia range will make its first appearance in February next year as
part of a new offering designed to help problem skin. The campaign
breaks in April.
The advertising business, which is expected to be worth around pounds 1
million, was awarded without a pitch. St Luke’s already handles Boots’
17 and No 7 ranges of cosmetics.
